“…It is a specific marker for neurons and peripheral neuroendocrine cells and so the most reliable tumor marker in the diagnosis, prognosis, and post-treatment of small-cell lung cancer. NSE being a human brain protein is present in about 0.4–2.2% (>5 ng mL –1 ) of total soluble protein of the brain, and excessive increase in such levels indicates a metastatic disease such as melanoma, seminoma, renal cell carcinoma, carcinoid tumors, Guillain-Barre syndrome, Creutzfeldt-Jakob disease, and so on. , The amount of NSE present in the brain predicts quantifiable measures of brain damage, which lead to strokes, hemorrhage, seizures, etc . Recently, reports have published sufficient data of COVID-19 positive patients showing the elevated level of NSE, signifying the role of NSE as a potential clinical biomarker for COVID-19 because it primarily targets human respiratory and neurological systems. , …”